Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA—clinical lessons in eosinophil-targeted therapy - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical Insights: Transitioning from Misdiagnosis to Effective Management of ANCA-Negative Severe EGPA with Mepolizumab—Lessons in Eosinophil-Directed Therapy

  • By

  • Ju-Zhang Li

  • Si-Yao Guan

  • Qiao-Zhen Wu

  • Jiang-Nan Zheng

  • July 8, 2026

Share

Original Source(s)

Related Content